Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Annals of Pediatric Endocrinology & Metabolism ; : 34-40, 2019.
Artigo em Inglês | WPRIM | ID: wpr-762592

RESUMO

PURPOSE: Urinary calcium creatinine ratio (UCaCrR) is a reliable indicator for monitoring hypercalciuria following vitamin D supplementation. However, the reference range varies from region to region. Previous studies did not take vitamin D and parathyroid hormone status into account while evaluating UCaCrR. Hence, we undertook this study to establish the 95th percentile of UCaCrR as an indicator of hypercalciuria in North Indian children and adolescents. METHODS: Four hundred seventy-three participants (boys 62.2%, girls 37.8%) with adequate dietary calcium intake, normal serum levels of 25-hydroxy-vitamin D (>20 ng/mL), and without secondary hyperparathyroidism following supplementation were selected for evaluation of UCaCrR. RESULTS: The mean age and body mass index of subjects were 11.2±2.6 years and 18.0±3.6 kg/m2, respectively. The 95th percentile of UCaCrR in the study population was 0.126. The mean, median, and 95th percentile of UCaCrR was significantly higher in prepubertal children (age ≤10 years) (0.0586±0.0374, median=0.0548, 95th percentile=0.136) compared to those >10 years old (0.0503±0.0363, median=0.0407, 95th percentile=0.123, P=0.02). No significant difference in UCaCrR was observed between genders and different weight categories. CONCLUSIONS: UCaCrR of 0.13 defines the cutoff value for hypercalciuria in North Indian children and adolescents with adequate dietary intake of calcium and sufficient serum vitamin D levels.


Assuntos
Adolescente , Criança , Feminino , Humanos , Índice de Massa Corporal , Cálcio , Cálcio da Dieta , Creatinina , Hipercalciúria , Hiperparatireoidismo Secundário , Hormônio Paratireóideo , Valores de Referência , Vitamina D
2.
Singapore medical journal ; : e117-9, 2012.
Artigo em Inglês | WPRIM | ID: wpr-334462

RESUMO

Sudden ascent to high altitudes beyond 2,438 m can cause life-threatening complications such as acute mountain sickness and high altitude cerebral and pulmonary oedema. We present a case of pituitary apoplexy in a young man who ascended to high altitude gradually, after proper acclimatisation. He developed headache, nausea, vomiting and persistent hypotension. Magnetic resonance imaging revealed an enlarged pituitary gland with haemorrhage. His hormonal estimation showed acute adrenal insufficiency due to corticotropin deficiency. The patient responded well to conservative medical management with hormonal replacement therapy. This is most likely the first reported case of high altitude-induced pituitary apoplexy in the literature.


Assuntos
Adulto , Humanos , Masculino , Aclimatação , Insuficiência Adrenal , Hormônio Adrenocorticotrópico , Altitude , Doença da Altitude , Encéfalo , Patologia , Terapia de Reposição Hormonal , Métodos , Hipotensão , Hemorragias Intracranianas , Imageamento por Ressonância Magnética , Métodos , Apoplexia Hipofisária , Diagnóstico , Hipófise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA